The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Nuclear Medicine Market At The End Of The 2026–2030 Forecast Period?
The nuclear medicine market has experienced substantial expansion in recent years. It is projected to increase from $10.18 billion in 2025 to $11.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. During the historic period, this growth was influenced by factors including restricted access to nuclear imaging equipment, the high cost of radiopharmaceuticals, a shortage of trained personnel, limited hospital and diagnostic center infrastructure, and low patient awareness.
The nuclear medicine market is projected for significant expansion over the upcoming years. Its valuation is anticipated to reach $17.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This expansion during the projected period stems from several factors, including an escalating need for sophisticated diagnostic and therapeutic methods, growing governmental efforts in cancer and cardiac treatment, wider integration into hospitals and diagnostic facilities, innovations in radiopharmaceuticals and imaging technologies, and enhanced patient understanding coupled with higher healthcare spending. Key developments expected within this period encompass a greater acceptance of diagnostic imaging approaches, expanded application of therapeutic radiopharmaceuticals, a surge in the requirement for PET and SPECT scans, intensified concentration on oncology and cardiology applications, and broader deployment across hospitals and diagnostic centers.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp
What Primary Drivers Are Shaping The Development Of The Nuclear Medicine Market?
The rising consistency and widespread occurrence of cardiovascular disease (CVD) and cancer are projected to stimulate the expansion of the nuclear medicine market in the future. Cardiovascular diseases (CVDs) encompass various heart and blood vessel conditions, while cancer involves cells multiplying uncontrollably and spreading throughout the body. Nuclear cardiac imaging offers a faster method for diagnosing heart-related illnesses. Additionally, nuclear medicine therapy provides a cancer treatment approach that can be employed either alongside or following other therapeutic interventions, including surgery and chemotherapy. Consequently, the increasing consistency and prevalence of cardiovascular disease and cancer heighten the demand for the nuclear medicine market. For instance, in January 2023, the American Cancer Society Inc., a US-based non-profit health organization, projected 1,958,310 new cancer diagnoses in the US, which represents an increase from over 1,918,030 new cancer cases recorded in 2022. Thus, the rising constancy and prevalence of cardiovascular diseases and cancer are serving as key drivers for the nuclear medicine market.
What Segment Types Make Up The Nuclear Medicine Market?
The nuclear medicine market covered in this report is segmented –
1) By Type: Diagnostic, Therapeutic
2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras
2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents
Which Market Trends Are Creating New Opportunities In The Nuclear Medicine Market?
Leading companies active in the nuclear medicine market are focused on developing innovative solutions, including nuclear medicine cyclotrons, to boost the production of radiopharmaceuticals and enhance diagnostic imaging capabilities. Nuclear medicine Cyclotrons are specialized particle accelerators that create radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals utilized in procedures such as positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, launched its inaugural batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are vital for nuclear medicine, facilitating the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, thereby improving capabilities in early disease detection and personalized treatment.
Who Are The Key Players Driving Competition In The Nuclear Medicine Market?
Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC
Read the full nuclear medicine market report here:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
How Does The Nuclear Medicine Market Perform Across Major Global Regions?
North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Nuclear Medicine Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp
Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company
Inotropic Agents Global Market Report
https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report
Orthobiologics Global Market Report
https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report
Spatial Omics Global Market Report
https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model